|
|
|||||||||||||||
|
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español | |||||||||
| Página principal > Artículos > Artículos publicados > Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain |
| Fecha: | 2024 |
| Resumen: | Background: Community-acquired (CA) and healthcare-associated (HCA) infections caused by carbapenemase-producing Enterobacterales (CPE) are not well characterized. The objective was to provide detailed information about the clinical and molecular epidemiological features of nosocomial, HCA and CA infections caused by carbapenemase-producing Klebsiella pneumoniae (CP-Kp) and Escherichia coli (CP-Ec). Methods: A prospective cohort study was performed in 59 Spanish hospitals from February to March 2019, including the first 10 consecutive patients from whom CP-Kp or CP-Ec were isolated. Patients were stratified according to acquisition type. A multivariate analysis was performed to identify the impact of acquisition type in 30-day mortality. Results: Overall, 386 patients were included (363 [94%] with CP-Kp and 23 [6%] CP-Ec); in 296 patients (76. 3%), the CPE was causing an infection. Acquisition was CA in 31 (8. 0%) patients, HCA in 183 (47. 4%) and nosocomial in 172 (48. 3%). Among patients with a HCA acquisition, 100 (54. 6%) had been previously admitted to hospital and 71 (38. 8%) were nursing home residents. Urinary tract infections accounted for 19/23 (82. 6%), 89/130 (68. 5%) and 42/143 (29. 4%) of CA, HCA and nosocomial infections, respectively. Overall, 68 infections (23%) were bacteremia (8. 7%, 17. 7% and 30. 1% of CA, HCA and nosocomial, respectively). Mortality in infections was 28% (13%, 14. 6% and 42. 7% of CA, HCA and nosocomial, respectively). Nosocomial bloodstream infections were associated with increased odds for mortality (adjusted OR, 4. 00; 95%CI 1. 21-13. 19). Conclusions: HCA and CA infections caused by CPE are frequent and clinically significant. This information may be useful for a better understanding of the epidemiology of CPE. |
| Ayudas: | Ministerio de Economía y Competitividad RD16/0016/0003 Ministerio de Economía y Competitividad RD16/0016/0011 Ministerio de Economía y Competitividad RD16/0016/0007 Ministerio de Economía y Competitividad RD16/0016/0006 Ministerio de Economía y Competitividad RD16/0016/0004 Ministerio de Economía y Competitividad RD16/0016/0001 Ministerio de Economía y Competitividad RD16/0016/0010 Ministerio de Economía y Competitividad RD16/0016/0008 Instituto de Salud Carlos III PMP22/00092 |
| Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
| Lengua: | Anglès |
| Documento: | Article ; recerca ; Versió publicada |
| Materia: | Carbapenem resistant Enterobacterales ; Clinical features ; KPC-3 ; OXA-48 ; Risk factors |
| Publicado en: | Infection, Vol. 52, Num. 6 (December 2024) , p. 2231-2240, ISSN 1439-0973 |
10 p, 688.3 KB |